Taken together, our results suggest that the use of a P-glycoprotein inhibitor combined with oxaliplatin or irinotecan chemotherapy should be an alternative therapy for advanced or drug resistant colon cancer cases [66]. This evidence concerns the gene ABCB1 and colonic neoplasm.